(19)
(11) EP 2 640 715 A1

(12)

(43) Date of publication:
25.09.2013 Bulletin 2013/39

(21) Application number: 11791704.7

(22) Date of filing: 17.11.2011
(51) International Patent Classification (IPC): 
C07D 401/14(2006.01)
A61K 31/506(2006.01)
A61P 29/00(2006.01)
C07D 413/14(2006.01)
A61P 35/00(2006.01)
A61P 37/00(2006.01)
(86) International application number:
PCT/US2011/061141
(87) International publication number:
WO 2012/068343 (24.05.2012 Gazette 2012/21)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 17.11.2010 US 414558 P

(71) Applicant: Amgen Inc.
Thousand Oaks, California 91320-1799 (US)

(72) Inventors:
  • CUSHING, Timothy D.
    Pacifica California 94044 (US)
  • LOHMAN, Julia Winslow
    San Francisco California 94131 (US)
  • SHIN, Youngsook
    Emeryville California 94608 (US)

(74) Representative: HOFFMANN EITLE 
Patent- und Rechtsanwälte Arabellastrasse 4
81925 München
81925 München (DE)

   


(54) QUINOLINE DERIVATIVES AS PIK3 INHIBITORS